GlycoMimetics Q4 EPS $(0.14) Beats $(0.15) Estimate, Cash Balance of $41.8M
Portfolio Pulse from Benzinga Newsdesk
GlycoMimetics (NASDAQ:GLYC) reported a Q4 EPS loss of $(0.14), surpassing the consensus estimate of $(0.15) by 6.67%. This marks a 26.32% improvement over the previous year's Q4 loss of $(0.19) per share. The company also reported a cash balance of $41.8M.
March 27, 2024 | 11:02 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
GlycoMimetics reported a smaller than expected Q4 EPS loss and showed improvement over the previous year, with a stable cash balance.
Beating EPS estimates and showing year-over-year improvement are positive indicators for investors, suggesting operational efficiency and potential for future growth. The reported cash balance provides a cushion and financial stability, further supporting a positive outlook for GLYC in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100